These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 10936789)
41. Cell death signaling in the cerebellum in Creutzfeldt-Jakob disease. Puig B; Ferrer I Acta Neuropathol; 2001 Sep; 102(3):207-15. PubMed ID: 11585244 [TBL] [Abstract][Full Text] [Related]
42. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. Aggarwal S; Gupta S J Immunol; 1998 Feb; 160(4):1627-37. PubMed ID: 9469419 [TBL] [Abstract][Full Text] [Related]
43. [Expression and clinical significance of HBsAg and HBcAg in hepatocytes in chronic hepatitis B]. Wang GS; Wang MM; Xie QL; Ming L; Jiang XN; Chen LW; Liu MH Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):287-9. PubMed ID: 15161505 [TBL] [Abstract][Full Text] [Related]
44. The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. Terradillos O; de La Coste A; Pollicino T; Neuveut C; Sitterlin D; Lecoeur H; Gougeon ML; Kahn A; Buendia MA Oncogene; 2002 Jan; 21(3):377-86. PubMed ID: 11821950 [TBL] [Abstract][Full Text] [Related]
45. Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis. Hayashi N; Mita E J Viral Hepat; 1999 Sep; 6(5):357-65. PubMed ID: 10607251 [TBL] [Abstract][Full Text] [Related]
46. [Expressions of Bcl-2, Bax and Bak proteins in liver tissues of hepatitis B patients and their significance]. Zhang B; Zhang D; Ma Y Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):74-6. PubMed ID: 10488411 [TBL] [Abstract][Full Text] [Related]
47. The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis. Sharief MK; Douglas M; Noori M; Semra YK J Neuroimmunol; 2002 Apr; 125(1-2):155-62. PubMed ID: 11960652 [TBL] [Abstract][Full Text] [Related]
48. Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. Druilhe A; Wallaert B; Tsicopoulos A; Lapa e Silva JR; Tillie-Leblond I; Tonnel AB; Pretolani M Am J Respir Cell Mol Biol; 1998 Nov; 19(5):747-57. PubMed ID: 9806739 [TBL] [Abstract][Full Text] [Related]
49. Apoptosis in chronic rejection of human cardiac allografts. Xu B; Sakkas LI; Slachta CA; Goldman BI; Jeevanandam V; Oleszak EL; Platsoucas CD Transplantation; 2001 Apr; 71(8):1137-46. PubMed ID: 11374416 [TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical evaluation of Bcl-2 gene family expression in liver of hepatitis C and cirrhotic patients: a novel mechanism to explain the high incidence of hepatocarcinoma in cirrhotics. Frommel TO; Yong S; Zarling EJ Am J Gastroenterol; 1999 Jan; 94(1):178-82. PubMed ID: 9934751 [TBL] [Abstract][Full Text] [Related]
51. Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis. Itakura M; Mori S; Park NH; Bonavida B Int J Oncol; 2000 Mar; 16(3):591-7. PubMed ID: 10675494 [TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical study of the apoptotic mechanisms in the intestinal mucosa during children's coeliac disease. Ehrmann J; Kolek A; Kod'ousek R; Zapletalová J; Lísová S; Murray PG; Drábek J; Kolár Z Virchows Arch; 2003 May; 442(5):453-61. PubMed ID: 12698366 [TBL] [Abstract][Full Text] [Related]
53. [Study on expression of Fas/FasL and HBV antigens in liver tissue of patients with hepatitis B]. Wang H; Hu J; Zhu K Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):12-5. PubMed ID: 12526294 [TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical study of the expression of BCL-2, PCNA and P53 proteins in the patients with hepatitis B. The pilot study. Ehrmann J; Jezdinská V; Ehrmann J; Galuzsková D; Krc I; Vojtĕsek B Acta Univ Palacki Olomuc Fac Med; 1996; 140():83-5. PubMed ID: 9431700 [TBL] [Abstract][Full Text] [Related]
55. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Lorenz HM; Grünke M; Hieronymus T; Herrmann M; Kühnel A; Manger B; Kalden JR Arthritis Rheum; 1997 Feb; 40(2):306-17. PubMed ID: 9041943 [TBL] [Abstract][Full Text] [Related]
56. Apoptosis in different cutaneous manifestations of lupus erythematosus. Baima B; Sticherling M Br J Dermatol; 2001 May; 144(5):958-66. PubMed ID: 11359381 [TBL] [Abstract][Full Text] [Related]
57. Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas/fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS. Di Renzo M; Serrano D; Zhou Z; George I; Becker K; Cunningham-Rundles C Clin Exp Immunol; 2001 Jul; 125(1):117-22. PubMed ID: 11472434 [TBL] [Abstract][Full Text] [Related]
58. Characterization of the expanded T cell population in infectious mononucleosis: apoptosis, expression of apoptosis-related genes, and Epstein-Barr virus (EBV) status. Verbeke CS; Wenthe U; Bergler WF; Zentgraf H Clin Exp Immunol; 2000 May; 120(2):294-300. PubMed ID: 10792379 [TBL] [Abstract][Full Text] [Related]
59. [The role of Fas/FasL system in induction of hepatocyte apoptosis in chronic viral hepatitides]. Dmitrieva EV; Moskaleva EIu; Kogan EA; Bueverov AO; Belushkina NN; Ivashkin VT; Severin ES; Pal'tsev MA Arkh Patol; 2003; 65(6):13-7. PubMed ID: 14964961 [TBL] [Abstract][Full Text] [Related]
60. Expression of perforin and Fas ligand mRNA in the liver of viral hepatitis. Tagashira M; Yamamoto K; Fujio K; Nagano T; Okamoto R; Ibuki N; Yabushita K; Matsumura S; Okano N; Tsuji T J Clin Immunol; 2000 Sep; 20(5):347-53. PubMed ID: 11051276 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]